Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Wortmannin alters the transferrin receptor endocytic pathway in vivo and in vitro.

Spiro DJ, Boll W, Kirchhausen T, Wessling-Resnick M. Wortmannin alters the transferrin receptor endocytic pathway in vivo and in vitro. Mol Biol Cell. 1996 Mar; 7(3):355-67.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.